Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

Sanam Loghavi, Naveen Pemmaraju, Rashmi Kanagal-Shamanna, Meenakshi Mehrotra, L. Jeffrey Medeiros, Raja Luthra, Pei Lin, Yang Huh, Hagop M. Kantarjian, Jorge E. Cortes, Srdan Verstovsek, Keyur P. Patel

Research output: Contribution to journalLetterpeer-review

18 Scopus citations
Original languageEnglish (US)
Pages (from-to)3360-3363
Number of pages4
Issue number21
StatePublished - 2015
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this